Safety and Efficacy Study of CC312 for Moderate to Severe SLE

Clinical trial NCT07177911 · RECRUITING

Trial details

NCT number: NCT07177911
Sponsor: CytoCares Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

SLE - Systemic Lupus Erythematosus

Start date: 2025-09-11
Primary completion: 2027-09-10
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.